These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 487531)

  • 1. Mechanism of action of methyldopa in the rat. Role of 3-O-methylated metabolites.
    Zavisca FG; Breau AP; Wurtman RJ
    Circ Res; 1979 Nov; 45(5):684-90. PubMed ID: 487531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central inhibitory effect of alpha-methyldopa on blood pressure, heart rate and body temperature of renal hypertensive rats.
    Nijkamp FP; Ezer J; De Jong W
    Eur J Pharmacol; 1975 Apr; 31(2):243-9. PubMed ID: 1149791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of the antihypertensive action of DL-alpha-monofluoromethyldopa: implications for the role of the sympathetic nervous system in maintenance of elevated blood pressure in spontaneously hypertensive rats.
    Fozard JR; Möhring J; Palfreyman MG; Koch-Weser J
    J Cardiovasc Pharmacol; 1981; 3(5):1038-49. PubMed ID: 6168849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of the antihypertensive action of -methyldopa in hypertensive rats.
    Day MD; Roach AG; Whiting RL
    Eur J Pharmacol; 1973 Mar; 21(3):271-80. PubMed ID: 4196583
    [No Abstract]   [Full Text] [Related]  

  • 5. Homologs of dopa, alpha-methyldopa, and dopamine as potential cardiovascular drugs.
    Winn M; Rasmussen R; Minard F; Kyncl J; Plotnikoff N
    J Med Chem; 1975 Apr; 18(4):434-7. PubMed ID: 1079053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression of sympathetic nervous function by DL-alpha-monofluoromethyldopa, an enzyme-activated, irreversible inhibitor of L-aromatic amino acid decarboxylase.
    Fozard JR; Spedding M; Palfreyman MG; Wagner J; Möhring J; Koch-Weser J
    J Cardiovasc Pharmacol; 1980; 2(3):229-45. PubMed ID: 6156322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New centrally acting antihypertensive drugs related to methyldopa and clonidine.
    Sweet CS
    Hypertension; 1984; 6(5 Pt 2):II51-6. PubMed ID: 6094350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between the antihypertensive activity of methyldopa and the appearance of its metabolites in the heart and brain of the hypertensive rat].
    Cohen Y; Wepierre J; Jacquot C; Rapin J
    Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):348-60. PubMed ID: 4827419
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction of DOPA decarboxylase inhibitors with the effect of alpha-methyldopa on blood pressure and tissue monoamines in rats.
    Henning M
    Acta Pharmacol Toxicol (Copenh); 1969; 27(2):135-48. PubMed ID: 5819569
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of the antihypertensive drugs alpha-methyldopa and hydralazine on the performance of spontaneously hypertensive rats in the elevated plus-maze.
    Rosa WC; Oliveira GM; Nakamura-Palacios EM
    Braz J Med Biol Res; 1994 Jan; 27(1):55-9. PubMed ID: 8173530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the role of alpha-methyldopamine in the antihypertensive effect of alpha-methyldopa.
    Waldmeier P; Hedwal PR; Maître L
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(3):303-14. PubMed ID: 169487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of alpha-methyldopa on blood pressure in the anaesthetized dog.
    Blower PR; Poyser RH; Robertson MI
    J Pharm Pharmacol; 1976 May; 28(5):437-40. PubMed ID: 6754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of the hypotensive action of methyldopa in normal and immunosympathectomized rats.
    Ayitey-Smith E; Varma DR
    Br J Pharmacol; 1970 Oct; 40(2):186-93. PubMed ID: 5492891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further studies on the inhibition of monoamine synthesis by monofluoromethyldopa.
    Bey P; Jung MJ; Koch-Weser J; Palfreyman MG; Sjoerdsma A; Wagner J; Zraïka M
    Br J Pharmacol; 1980 Dec; 70(4):571-6. PubMed ID: 7470730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential blood pressure responses to intracisternal clonidine, alpha-methyldopa, and 6-hydroxydopamine in conscious normotensive and spontaneously hypertensive rats.
    Head GA; de Jong W
    J Cardiovasc Pharmacol; 1986; 8(4):735-42. PubMed ID: 2427812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of central and peripheral mechanisms in the action of alpha-methyldopa on blood pressure and renin secretion.
    Frankel RJ; Reid IA; Ganong WF
    J Pharmacol Exp Ther; 1977 May; 201(2):400-5. PubMed ID: 323462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of central serotonin neurons in the hypotensive action of methyldopa in the rat.
    Choy VJ; Chalmers J
    Clin Exp Pharmacol Physiol; 1984; 11(1):37-44. PubMed ID: 6713735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alpha-methyldopa and brain monoamines].
    Niwa M; Kawano T; Fujita Y; Maemura S; Ozaki M
    Nihon Yakurigaku Zasshi; 1982 May; 79(5):451-9. PubMed ID: 6813206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The plasma noradrenaline and growth hormone response to alpha-methyldopa and clonidine in hypertensive subjects.
    Struthers AD; Brown MJ; Adams EF; Dollery CT
    Br J Clin Pharmacol; 1985 Mar; 19(3):311-7. PubMed ID: 3986086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of monoamine synthesis by irreversible blockade of aromatic aminoacid decarboxylase with alpha-monofluoromethyldopa.
    Jung MJ; Palfreyman MG; Wagner J; Bey P; Ribereau-Gayon G; Zraïka M; Koch-Weser J
    Life Sci; 1979 Mar; 24(11):1037-42. PubMed ID: 449607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.